Brief: CSPC Pharmaceutical Announces Exclusive License Agreement For Sysa1801 With Elevation Oncology, Inc.
28/07/2022 02:21
July 28 (Reuters) - CSPC Pharmaceutical Group Ltd 1093.HK :
* ANNOUNCES EXCLUSIVE LICENSE AGREEMENT FOR SYSA1801 WITH
ELEVATION ONCOLOGY, INC.
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7jwy31
Further company coverage: 1093.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing